The analysis looked at subjects given the 100-microgram dose being tested in the much larger Phase III trial. Moderna said the immune responses in those aged between ages 56 and 70, above age 70 and those 18 to 55-years-old were similar.
from Hindustan Times - lifestyle https://ift.tt/2FYEElf
Post Top Ad
Wednesday, 26 August 2020
Moderna Covid-19 vaccine likely to work well on older adults: Study
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment